长非编码RNA和在肺癌中演变的耐药性
Meibin Wang1, Yujie Fu2, Chuyue Zhong3
1The Dingli Clinical college of Wenzhou Medical University, Wenzhou 325000, PR China.
Heliyon
|December 13, 2023
概括
长非编码RNAs (lncRNAs) 显著促进非小细胞肺癌 (NSCLC) 治疗耐药性. 本综述总结了lncRNAs如何调解NSCLC患者对化疗和向药物的耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 在全球范围内,非小细胞肺癌 (NSCLC) 的发病率和死亡率很高.
- 基于的化疗和向疗法为晚期NSCLC患者提供了好处.
- 治疗耐药性,无论是原发性还是获得性,都会导致NSCLC的治疗失败和瘤进展.
研究的目的:
- 在NSCLC中系统地审查 lncRNA介导的化学疗法耐药性的机制.
- 阐明 lncRNAs 在NSCLC中调解针对性治疗药物的耐药性的作用.
- 在NSCLC耐药性中提供IncRNA功能的综合总结.
主要方法:
- 对研究lncRNAs和NSCLC中药物耐药性的文献综述.
- 系统地总结了所识别的机制.
- 对 lncRNA 参与化疗和针对性治疗耐药性的分析.
主要成果:
- 长非编码RNAs (lncRNAs) 在NSCLC发育中发挥着关键作用.
- lncRNAs在调解化学疗法和向治疗的耐药性方面发挥着至关重要的作用.
- 多种复杂的机制是NSCLC中 lncRNA介导的耐药性的基础.
结论:
- lncRNAs是非小细胞肺癌中耐药性的关键调节者.
- 了解 lncRNA介导的抗性机制对于克服治疗失败至关重要.
- 向lncRNAs可能为克服NSCLC耐药性提供新的治疗策略.
更多相关视频
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
13.7K
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Types of RNA
63.8K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
